Browse Articles
Discover research articles across all indexed journals
Exploring the dual impact of nanoparticles on human well-being: A comprehensive review of risks and benefits
Spatiotemporal Programmability of 3D Chiral Color Units Driven by Ink Spontaneous Diffusion toward Customized Printing (Adv. Mater. 4/2025)
Hydrothermal synthesis of nitrogen-doped CQDs for detection of Cr6+ and removal of MB dye in wastewater
Piezoelectric Heterojunctions as Bacteria‐Killing Bone‐Regenerative Implants (Adv. Mater. 1/2025)
Diverse approach for the evaluation of antibacterial, antioxidant, and cytotoxicity properties: Plant-mediated synthesis of AgO, ZnO and AgO-ZnO bimetallic nanoparticles using Theobroma cacao leaf extract
Angular‐Inertia Regulated Stable and Nanoscale Sensing of Single Molecules Using Nanopore‐In‐A‐Tube (Adv. Mater. 2/2025)
Therapeutic profiling of Saraca indica bark oil silver nanoparticles: Bioactivity and cytocompatibility in human keratinocyte (HaCaT) cells
Supramolecular Architectures of Dendritic Polymers Provide Irreversible Inhibitor to Block Viral Infection (Adv. Mater. 3/2025)
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?
Lysozyme functionalized zinc-oxide nanoparticles: Synthesis, characterization, and antibacterial assessment against Staphylococcus aureus with futuristic application in wastewater monitoring
Ultraflexible Vertical Corbino Organic Electrochemical Transistors for Epidermal Signal Monitoring (Adv. Mater. 4/2025)
Erectile dysfunction common within the first year after rectal cancer surgery
Combined Photothermal‐Photodynamic Therapy by Ce6 loaded on MoO2 functional nanoplatform
Development of an Inhalable DNA Tetrahedron MicroRNA Sponge (Adv. Mater. 4/2025)
Cancer statistics, 2025
ABSTRACT Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2021) and mortality data collected by the National Center for Health Statistics (through 2022). In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are projected to occur in the United States. The cancer mortality rate continued to decline through 2022, averting nearly 4.5 million deaths since 1991 because of smoking reductions, earlier detection for some cancers, and improved treatment. Yet alarming disparities persist; Native American people bear the highest cancer mortality, including rates that are two to three times those in White people for kidney, liver, stomach, and cervical cancers. Similarly, Black people have two‐fold higher mortality than White people for prostate, stomach, and uterine corpus cancers. Overall cancer incidence has generally declined in men but has risen in women, narrowing the male‐to‐female rate ratio (RR) from a peak of 1.6 (95% confidence interval, 1.57–1.61) in 1992 to 1.1 (95% confidence interval, 1.12–1.12) in 2021. However, rates in women aged 50–64 years have already surpassed those in men (832.5 vs. 830.6 per 100,000), and younger women (younger than 50 years) have an 82% higher incidence rate than their male counterparts (141.1 vs. 77.4 per 100,000), up from 51% in 2002. Notably, lung cancer incidence in women surpassed that in men among people younger than 65 years in 2021 (15.7 vs. 15.4 per 100,000; RR, 0.98, p = 0.03). In summary, cancer mortality continues to decline, but future gains are threatened by rampant racial inequalities and a growing burden of disease in middle‐aged and young adults, especially women. Continued progress will require investment in cancer prevention and access to equitable treatment, especially for Native American and Black individuals.